Advent Capital Management »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Advent Capital Management

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Advent Capital Management from 13F filings

Historical chart of Advent Capital Management investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Advent Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Advent Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $137k 115k 1.19
2024-06-30 $26M 23M 1.12
2024-03-31 $49M 50M 0.98
2023-12-31 $52M 56M 0.93
2023-09-30 $70M 74M 0.94

More positions owned by Advent Capital Management

Bank Of America Corp Conv Pfd (BAC.PL)
Wells Fargo & Company Conv Pfd (WFC.PL)
Dexcom Conv (Principal)
Apollo Global Management Conv Pfd (APO.PA)
Ford Motor Company Conv (Principal)
Cms Energy Corp Conv (Principal)
Ventas Realty Conv (Principal)
Centerpoint Energy Conv (Principal)
Akamai Technologies Conv (Principal)
Wayfair Conv (Principal)
Uber Technologies Conv (Principal)
Nextera Energy Conv Pfd (NEE.PR)
Draftkings Holdings Conv (Principal)
Duke Energy Corp Conv (Principal)
iShares Russell 2000 Index Put Option (IWM)

View all positions for Advent Capital Management

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&G
Citadel Advisors
MacKay Shields
Lazard Asset Management
Calamos Advisors
Polar Securities
BlackRock
Wolverine Asset Management
Ing Investment Management
Wells Fargo & Company
CNH Partners
State Street Corporation
BlackRock
Absolute Investment Advisers
Glazer Capital

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1